Scientific Sessions 2025  /  Innovations in Valvular Heart Disease: Talks from Basic Science to Clinical Trials to Breakthrough Innovations in Surgical and Transcatheter Therapies  /  Artificial Intelligence in Diagnosing Valvular Heart Disease--the Future is Now
Logo

American Heart Association

  74
  0

Final ID:

Artificial Intelligence in Diagnosing Valvular Heart Disease--the Future is Now

  • Holste, Gregory  ( Yale School of Medicine , New Haven , Connecticut , United States )
  • Namasivayam, Mayooran  ( St Vincent's Hospital Sydney , Darlinghurst , New South Wales , Australia )
  • Topol, Eric  ( SCRIPPS HEALTH , La Jolla , California , United States )
    • Author Disclosures:
    Gregory Holste: DO NOT have relevant financial relationships | Mayooran Namasivayam: No Answer | Eric Topol: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovations in Valvular Heart Disease: Talks from Basic Science to Clinical Trials to Breakthrough Innovations in Surgical and Transcatheter Therapies

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Basic Science Revolution in Valvular Heart Disease

Aikawa Elena, Gray Laman, Srivastava Deepak, Murry Chuck

Innovations in AS Diagnosis by Electronic Provider Notification to Facilitate the Recognition and Management of Valvular Heart Disease

Tanguturi Varsha, Elmariah Sammy, Abou-karam Roukoz, Cheng Fangzhou

More abstracts from these authors:
PanEcho: Complete AI-enabled echocardiography interpretation with multi-task deep learning

Holste Gregory, Oikonomou Evangelos, Wang Zhangyang, Khera Rohan

Artificial Intelligence: towards the prediction, detection, and prevention of atrial fibrillation and stroke

Noseworthy Peter, Topol Eric

You have to be authorized to contact abstract author. Please, Login
Not Available